FDA Drug Shortages — Page 37

1,814 drug shortages total

Browse FDA drug shortages by generic name, company and status, with first-posted dates, from the FDA drug shortage database. RegDataLab tracks 1,814 drug shortages from official FDA sources, updated on an ongoing basis.

FDA Drug Shortages (page 37 of 37)
Drug shortagesDetails
Potassium Chloride Tablet, Extended ReleaseTo Be Discontinued — Teva Pharmaceuticals USA, Inc.
Busulfan InjectionNo longer listed by FDA — Mylan Institutional, A Viatris Company
Carbamazepine Capsule, Extended ReleaseTo Be Discontinued — Takeda Pharmaceuticals USA Inc.
Peginterferon alfa-2a InjectionResolved — Pharmaand GmbH (Pharma&)
Obeticholic Acid TabletNo longer listed by FDA — Intercept Pharmaceuticals
Lorazepam InjectionCurrent — Hikma Pharmaceuticals USA, Inc.
Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate TabletCurrent — Teva Pharmaceuticals USA, Inc.
Dexmedetomidine Hydrochloride InjectionCurrent — Pfizer Inc.
Morphine Sulfate InjectionCurrent — Hikma Pharmaceuticals USA, Inc.
Hydromorphone Hydrochloride InjectionCurrent — Hospira, Inc., A Pfizer Company
Ropivacaine Hydrochloride InjectionCurrent — Somerset Therapeutics, LLC
Everolimus TabletTo Be Discontinued — Endo Pharmaceuticals, Inc.
Bupivacaine Hydrochloride InjectionCurrent — Eugia US LLC
Bupivacaine Hydrochloride, Epinephrine Bitartrate InjectionCurrent — Fresenius Kabi USA, LLC
← Previous Page 37 of 37

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.